Home LiteratureArticle Details
PMID: 11606769 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression.

Toft DJ, Rosenberg SB, Bergers G, Volpert O, Linzer DI

Abstract

Proliferin (PLF) is an angiogenic placental hormone. We now report that PLF gene expression can also occur in a progressive fibrosarcoma mouse tumor cell model. PLF mRNA and protein are detectable at very low levels in cell lines derived from the mild noninvasive stage of tumor development. Expression is greatly augmented in cell lines from the aggressively invasive stage of development, a stage at which the tumor becomes highly angiogenic, and PLF expression remains high in cell lines from the end stage of fibrosarcoma. Activator protein 1 factors present at high levels in the more invasive stages of the tumor may in part allow for increased PLF expression, as cells from the mild stage in which c-jun and junB are stably expressed secrete levels of PLF comparable to that of the advanced stages. Secreted PLF protein is functionally important in tumor cell angiogenic activity, as demonstrated by the reduction of angiogenic activity in fibrosarcoma cell culture medium by immunodepletion of PLF. These results suggest that an extraembryonic genetic program, which has evolved to support fetal growth, may be reactivated in certain tumors and contribute to tumor growth.

MeSH Terms
Cells, Cultured Disease Progression Fibrosarcoma/genetics,pathology Gene Expression Regulation Glycoproteins/genetics Intercellular Signaling Peptides and Proteins Models, Biological Neovascularization, Pathologic/genetics Prolactin Transcription Factor AP-1/metabolism
Chemicals
Glycoproteins Intercellular Signaling Peptides and Proteins Prl2c2 protein, mouse Transcription Factor AP-1 Prolactin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Toft D J
Department of Biochemistry, Molecular Biology, and Cell Biology, Northwestern University, 2153 Sheridan Road, Evanston, IL 60208, USA.
Rosenberg S B
Bergers G
Volpert O
Linzer D I
References (31)
31 references, click to expand
  1. Signaling between the placenta and the uterus involving the mitogen-regulated protein/proliferins.
    Endocrinology. 1999 Nov;140(11):5239-49 PMID: 10537154
  2. Induction of megakaryocyte differentiation by a novel pregnancy-specific hormone.
    J Biol Chem. 1999 Jul 23;274(30):21485-9 PMID: 10409714
  3. Placental prolactins and the physiology of pregnancy.
    Recent Prog Horm Res. 2000;55:37-51; discussion 52 PMID: 11036932
  4. Mrp3, a mitogen-regulated protein/proliferin gene expressed in wound healing and in hair follicles.
    Endocrinology. 2001 May;142(5):2129-37 PMID: 11316781
  5. Selective stimulation by mitogens of incorporation of 35S-methionine into a family of proteins released into the medium by 3T3 cells.
    Cell. 1980 May;20(1):19-28 PMID: 6966975
  6. Nucleotide sequence of a growth-related mRNA encoding a member of the prolactin-growth hormone family.
    Proc Natl Acad Sci U S A. 1984 Jul;81(14):4255-9 PMID: 6087314
  7. Identification of proliferin mRNA and protein in mouse placenta.
    Proc Natl Acad Sci U S A. 1985 Jul;82(13):4356-9 PMID: 3859868
  8. Bovine papillomavirus genome elicits skin tumours in transgenic mice.
    Nature. 1986 Aug 14-20;322(6080):609-12 PMID: 3018579
  9. Expression of multiple proliferin genes in mouse cells.
    Mol Cell Biol. 1986 Sep;6(9):3283-6 PMID: 3785228
  10. Relationship between mitogen-regulated protein (MRP) and proliferin (PLF), a member of the prolactin/growth hormone family.
    Gene. 1987;51(2-3):163-70 PMID: 3596242
  11. Trophoblastic giant cells of the mouse placenta as the site of proliferin synthesis.
    Endocrinology. 1988 May;122(5):1761-8 PMID: 3359962
  12. Co-localization of elements required for phorbol ester stimulation and glucocorticoid repression of proliferin gene expression.
    Genes Dev. 1989 Jun;3(6):760-9 PMID: 2744462
  13. Obligatory wounding requirement for tumorigenesis in v-jun transgenic mice.
    Nature. 1990 Aug 23;346(6286):756-60 PMID: 2167455
  14. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.
    Proc Natl Acad Sci U S A. 1990 Sep;87(17):6624-8 PMID: 1697685
  15. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element.
    Science. 1990 Sep 14;249(4974):1266-72 PMID: 2119054
  16. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma.
    Cell. 1991 Sep 20;66(6):1095-104 PMID: 1717155
  17. The role of angiogenesis in tumor growth.
    Semin Cancer Biol. 1992 Apr;3(2):65-71 PMID: 1378311
  18. Invasion of the trophoblasts.
    Cell. 1992 Oct 30;71(3):355-7 PMID: 1423599
  19. Transcription factors junB and c-jun are selectively up-regulated and functionally implicated in fibrosarcoma development.
    Genes Dev. 1992 Dec;6(12A):2340-51 PMID: 1459456
  20. Characterization of a delayed early serum response region.
    Mol Cell Biol. 1994 Sep;14(9):6013-20 PMID: 8065334
  21. Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein.
    Science. 1994 Dec 2;266(5190):1581-4 PMID: 7527157
  22. Characterization of the mitogen-regulated protein (proliferin) receptor.
    Endocrinology. 1995 Jan;136(1):283-8 PMID: 7828542
  23. A transition in transcriptional activation by the glucocorticoid and retinoic acid receptors at the tumor stage of dermal fibrosarcoma development.
    EMBO J. 1995 May 15;14(10):2217-28 PMID: 7774580
  24. Luteotropic actions of placental lactogens at midpregnancy in the mouse.
    Endocrinology. 1995 Sep;136(9):3993-4003 PMID: 7649108
  25. Proliferin transport and binding in the mouse fetus.
    Endocrinology. 1997 Jan;138(1):149-55 PMID: 8977398
  26. A novel technique for culture of human dermal microvascular endothelial cells under either serum-free or serum-supplemented conditions: isolation by panning and stimulation with vascular endothelial growth factor.
    Exp Cell Res. 1997 Feb 1;230(2):244-51 PMID: 9024783
  27. GATA-2 and GATA-3 regulate trophoblast-specific gene expression in vivo.
    Development. 1997 Feb;124(4):907-14 PMID: 9043071
  28. The uteroplacental prolactin family and pregnancy.
    Biol Reprod. 1998 Feb;58(2):273-84 PMID: 9475377
  29. JunB is essential for mammalian placentation.
    EMBO J. 1999 Feb 15;18(4):934-48 PMID: 10022836
  30. Uterine natural killer cells are targets for a trophoblast cell-specific cytokine, prolactin-like protein A.
    Endocrinology. 1999 Jun;140(6):2711-20 PMID: 10342862
  31. Mrp4, a new mitogen-regulated protein/proliferin gene; unique in this gene family for its expression in the adult mouse tail and ear.
    Endocrinology. 2000 May;141(5):1863-71 PMID: 10803597
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2001-11-06
Epub
2001-00-23
Pages
13055-9
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC60823
Subset
IM
Grants
NCI NIH HHS · P30 CA060553 · United States
NICHD NIH HHS · HD24518 · United States
NCI NIH HHS · P30 CA60553 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com